GC Biopharma passes US preliminary review for immunoglobulin product < Pharma < Article – KBR

The FDA is expected to make a final decision on GC5107B by Jan. 13, 2024, under the Prescription Drug User Fee Act (PDUFA). If it wins the FDA …